Newsfeeds Archive - Page 15 of 194

1 minute read

Faraday Future Intelligent Electric Has Regained Compliance With Nasdaq Listing Rule 5605(B)(1)

October 17, 4:59 PM

As previously reported by Faraday Future Intelligent Electric Inc., a Delaware corporation (the "Company"), in its Current Report on From 8-K filed with the Securities and Exchange Commission ("SEC")

FFIC

1 minute read

M&A
News

‘SK Hynix Balks At Western Digital-Kioxia Memory Chip Merger’ – Nikkei Asia

By Charles Gross

October 17, 12:36 PM

https://asia.nikkei.com/Business/Tech/Semiconductors/SK-Hynix-balks-at-Western-Digital-Kioxia-memory-chip-merger

WDC

2 minute read

HII Is Awarded 5-Year $244M Contract To Integrate Minotaur Software Products Into Maritime Platforms

By Charles Gross

October 17, 12:34 PM

HII (NYSE:HII) announced today that its Mission Technologies division was awarded a $244 million task order to integrate Minotaur software products into maritime platforms for the U.S. Navy, U.S. Marine Corps and U.S. Coast Guard.

HII

1 minute read

News
Tech

Baidu Announced Launch Of ERNIE 4.0 Foundation Model, Leading A New Wave Of AI-Native Applications

By Charles Gross

October 17, 5:28 AM

Baidu, Inc. (NASDAQ:BIDU), a leading AI company with strong Internet foundation, today hosted its annual flagship technology conference Baidu World 2023 in Beijing, marking the conference's return to an offline

BIDU

1 minute read

FDA
News

FDA Approved KEYTRUDA For Treatment Of Patients With Resectable (T≥4 cm or N+) NSCLC In Combination With Chemotherapy As Neoadjuvant Treatment, Then Continued As A Single Agent As Adjuvant Treatment After Surgery

By Charles Gross

October 16, 7:02 PM

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the treatment of

MRK

1 minute read

The Real Good Food Company Priced 6,785,715 Share Offering Of Common Stock @ $2.10/Share

By Charles Gross

October 11, 7:22 PM

The Real Good Food Company, Inc. (NASDAQ:RGF) (the “Company”), a leading health and wellness frozen and refrigerated food company, today announced the pricing of an underwritten public offering of 6,785,715

RGF

2 minute read

Astria Therapeutics Priced 8,253,895 Share Offering Of Its Common Stock And Accompanying Common Stock Warrants To Purchase An Aggregate Of 6,190,418 Shares Of Common Stock, @ $6.514

By Charles Gross

October 11, 7:20 PM

Astria Therapeutics, Inc. (“Astria Therapeutics,” “Astria,” the “Company,” “our,” or “us”) (NASDAQ:ATXS), a biopharmaceutical company focused on developing

ATXS

1 minute read

Birkenstock Holding Priced 32,258,064 Share IPO @ $46.00/Share

By Charles Gross

October 10, 6:27 PM

Birkenstock Holding plc (“BIRKENSTOCK”) announced today the pricing of its initial public offering of 32,258,064 ordinary shares at a public offering price of $46.00 per share. BIRKENSTOCK is offering

BIRK

1 minute read

Earlier, GSK And Zhifei Announced Exclusive Strategic Vaccine Partnership In China; Zhifei Will Purchase Agreed Volumes Of Shingrix With A Value To GSK Of £2.5B In Total Over The Initial Three-year Period

By Charles Gross

October 9, 5:14 AM

GSK plc (NYSE:GSK) announced today that it has reached an exclusive agreement with Chongqing Zhifei Biological Products, Ltd. (Zhifei) to co-promote GSK’s shingles vaccine, Shingrix, in China for an initial

GSK

1 minute read

News

Ionis Statement About Results From An Analysis Of Exploratory Cardiac Endpoints In The Phase 3 NEURO-TTRansform Study Of Eplontersen

By Charles Gross

October 7, 3:53 PM

On Oct. 7, Ionis announced new results from a 66-week analysis of exploratory cardiac endpoints in the Phase 3 NEURO-TTRansform study of eplontersen, an investigational treatment for hereditary transthyretin-mediated

AZN